✦ LIBER ✦

1049 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE PLUS PEGINTERFERON AND RIBAVIRIN IN HCV GENOTYPE 1 PATIENTS: INTERIM ANALYSIS SHOWS INCREASE IN EVR

✍ Scribed by Bacon, B.; Shiffman, M.; Lim, J.; Berman, A.; Rustgi, V.; Keeffe, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2001 PHASE 2 RANDOMIZED, DOUBLE-BLIND, P

✍ Bacon, B.R.; Shiffman, M.L.; Lim, J.K.; Berman, A.; Rustgi, V.K.; Keeffe, E.B. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

1059 PHASE 2 RANDOMIZED, DOUBLE-BLIND, P

✍ Shiffman, M.; Ahmed, A.; Jacobson, I.; Pruitt, R.; Keeffe, E. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 57 KB

A Phase II, Randomized, Double-Blind, Pl

✍ Bruce R. Bacon; Mitchell L. Shiffman; Joseph K. Lim; Arthur Berman; Vinod K. Rus 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 90 KB

1188 PHASE 2 RANDOMIZED, DOUBLE-BLIND, P

✍ Shiffman, M.L.; Ahmed, A.; Jacobson, I.M.; Pruitt, R.E.; Keeffe, E.B. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Randomized, double-blind, placebo-contro

✍ Peter Ferenci; Elisabeth Formann; Hermann Laferl; Michael Gschwantler; Franz Hac 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Su1049 Faldaprevir Plus Pegylated Interf

✍ Jensen, Donald M.; Foster, Graham; Ferenci, Peter; Cooper, Curtis; Dieterich, Do 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 292 KB